The government has U-turned on its manifesto commitment to offer all workers protection against unfair dismissal from their ...
Day One Biopharmaceuticals (DAWN) announced three-year results from the OJEMDA pivotal Phase 2 FIREFLY-1 trial in an oral presentation at the 30th ...
Investor's Business Daily on MSN
Mersana Therapeutics Catapults 200% On Day One Bio's Surprise Buyout
Shares of Mersana Therapeutics catapulted early Thursday after Day One Biopharmaceuticals agreed to buy it for up to $285 ...
Day One Biopharmaceuticals, Inc. is rated a Strong Buy with robust product growth, pipeline expansion & strategic acquisition. Read more on DAWN stock here.
Tonight's Xbox Partner Preview showcase has now concluded, and we've got a fresh list of new day one Xbox Game Pass launches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback